A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy (Q57579980)
Jump to navigation
Jump to search
scientific article published on 13 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy |
scientific article published on 13 September 2007 |
Statements
A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy (English)
Dominique Spaeth
Gilles Romieu
Annick Bessems
Stephen R D Johnston
George M Manikhas
David J Dodwell
Youn C Park
Peter M De Porre
Juan J Perez Ruixo
13 September 2007